Healthcare -
Biotechnology - NASDAQ - US
$ 6.14
0.656 %
$ 520 M
Market Cap
-2.5
P/E
VERV - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss VERV - Verve Therapeutics, Inc.
272 K
LAST VALUE
78.69%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR